Lazard Asset Management LLC Makes New $153,000 Investment in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
Lazard Asset Management LLC bought a new position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund bought 11,602 shares of the company’s stock, valued at approximately $153,000. Several other large investors also recently added to or reduced their stakes in SNDX. Renaissance Technologies LLC bought a […]
Lazard Asset Management LLC bought a new position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund bought 11,602 shares of the company’s stock, valued at approximately $153,000. Several other large investors also recently added to or reduced their stakes in SNDX. Renaissance Technologies LLC bought a […]
